Two major projects are underway with HMC. The first focuses on identifying markers of Growth Hormone administration in sport doping, scheduled to begin in September 2025. The second project is dedicated to detecting metabolic markers of autologous blood transfusion in athletes, with recruitment currently in progress.
Partnership with Hamad Medical Corporation (HMC):
Category: Announcements
Collaboration
